Mr. Saransh Chaudhary featured in IndiaMed Today

Redefining the Fight Against AMR: Anti-Virulence Strategies and Phage Therapy Lead the Way

In the shadow of a mounting antimicrobial resistance (AMR) crisis, India stands at a critical crossroads. With drug-resistant infections claiming nearly 300,000 lives in 2019 alone, according to ICMR data, and resistance rates soaring to 80% for pathogens like carbapenem-resistant Acinetobacter baumannii, traditional antibiotics are losing ground fast. Overuse, inadequate diagnostics, and environmental factors have fueled this epidemic, demanding bold, next-generation defenses. As Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre, notes: Enter anti-virulence therapies and phage therapy precision tools that disarm pathogens and target them selectively, preserving our existing drugs while charting a path to sustainable infection control.

Antimicrobial resistance continues to accelerate at a pace that is now impossible to ignore. Overuse and misuse of anti...